Oral/Maxillofacial

FDA Approval for Organogenesis Inc’s Gintuit™ marks first cell-based product for use in dental market.

Despite losing Hemostase revenue, Cryolife has reported record Q4 and significant annual revenue growth, giving it optimistic outlook for the near term as it enacts global strategic initiatives.

Baxter’s previously advertised agreement to buy Synovis has now been consummated with the approval of Synovis’ shareholders.

Bacterin International Holdings, Inc. a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has signed an exclusive agreement with Jeil Medical Corporation for distribution in the U.S. and Canada of Jeil’s LeForte System.

Cohera Medical has announced that it has begun selling its lead product, TissuGlu® Surgical Adhesive, to hospitals and surgeons in three pilot territories in Germany.

Vibrating gel could restore lost voices

Two new endoscopic devices launched in the UK promise to improve the success of surgery for treatment of chronic sinusitis.

Apnex Medical, Inc., has received CE Mark approval for its Hypoglossal Nerve Stimulation (HGNS®) System for use by people who suffer from obstructive sleep apnea.

Bacterial cells have gene mutations that allow them to ‘stick’ to implanted medical devices

New technology offers one-source, customizable option for bone grafting space maintenance in oral-maxillofacial applications